Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
65 Cards in this Set
- Front
- Back
Parathyroid hormone
|
-Polypeptide made by parathyroid gland
-Released in response to decreased plasma calcium -Causes increased calcium and phosphate mobilization from bone |
|
PTH effect on osteoblasts and osteoclasts
|
Increased number of osteoblasts and osteoclasts which causes calcium mobilization
|
|
PTH effects on kidney
|
Decrease ca and increasd phosphate excretion
Increased activation of Vitamin D |
|
Active Vitamin D
|
1,25 dihydroxyvitamin D
|
|
PTH affect on GI tract
|
Vitamin D activation, which indirectly increases calcium absorption
|
|
Two forms of vitamin D
|
Ergocalciferol-D2-plants
Cholecalciferol-D3-animals |
|
Synthesis of Vitamin D
|
Formed from cholesterol by 7-dehydrocholesterol enzyme, along with UV radiation
|
|
Calcitriol
|
Most active form of vitamin D
1,25 dihydroxyvitamin D |
|
Activation of Vitamin D
|
Requires Liver (25 hydroxyvitaminD) and kidney (1,25)
Kidney is rate limiting step Activation in kidney is increased with PTH, low plasma ca and phosphate |
|
Estrogen Effects on calcium homeostasis
|
Preserves calcium in bone (unknown mechanism)
|
|
Glucocortoid effects on calcium homeostasis
|
At pharmacological levels (not physiological levels) it increases calcium resorption from bone
|
|
Calcitonin
|
-Polypeptide produced in thyroid
-Not vital to Calcium homeostasis -Modulates Vitamin D and PTH regulation -Released in response to increased plasma calcium |
|
Calcitonin's effects on bone
|
Direct inhibition of osteoclast activity-> decreased bone resorption
-may stimulate osteoblast formation |
|
Calcitonin's effects on Kidney
|
Increases calcium, phosphate, and other ion excretion
|
|
Net result of Calcitonin releases
|
Tones down serum calcium (and phosphate)
|
|
Is PTH orally available
|
NO, It's a polypeptide
-low oral availability -Rapid metabolism in KIDNEY and liver |
|
PTH administration
|
Must be by injection (parenteral)
|
|
PTH Mechanism of Action
|
Increases osteoblast number->increases plasma calcium levels
|
|
PTH indications
|
-Osteoporosis
|
|
Adverse affects of PTH
|
Hypercalcemia
(uncommon at low dose used) |
|
Contraindications of PTH use
|
Use with diphoshonates
|
|
Is Calcitonin orally available?
|
NO, It's a polypeptide
-low oral availability -Rapid metabolism |
|
Calcitonin Mechanism of action
|
-increases excretion of calcium and phosphate (and sodium, Mg, Cl)
-Decreases activity of osteoclasts->decreased bone resorption -Decreases plasma calcium levels |
|
Calcitonin half life
|
Very short T1/2, but salmon ct has longer halflife
metabolized in liver and kidney |
|
indications for Calcitonin
|
Pagets Disease
Osteoporosis To decrease Ca loss from bone and bone turnover Hypercalcemia of malignancy |
|
Adverse effects of Calcitonin
|
Hypocalcemia, uncommon due to escape of calcitonin in kidney
|
|
Vitamin D
|
pro-drug that must by activatied by 2 steps of hydroxylation 25-liver, 1-kidney
|
|
Calcifedial
|
25 hydroxyvitamin D
Converted to calcitriol in a HEALTHY KIDNEY |
|
Calcitriol
|
Most active vitamin D
1, 25 dihydroxy vitamin D |
|
Dihydrotachysterol (DHT)
|
Reduced form of Vitamin D2, activated by 25 hydroxylation in liver
useful in renal disease because it doesn't need a kidney |
|
Mechanism of action of Vitamin D
|
Increased plasma calcium by
-increasing absorption through the gut and bone deposition -increased release of Calcium from bone -Decreased excretion from kidneys |
|
Vitamin D bioavailability?
|
Yes-Readily absorpbed by gut IF bile salts present
-imparied absorption with biliary cirhosis, steatorrhea |
|
Vitamin D half-life and excretion
|
-T1/2 1-3 days, but it's stored in body tissues for long periods
-Excreted in Bile |
|
Therapeutic Uses of Vitamin D
|
-Rickets and osteomalacia
-osteoporosis -hypocalcemia -Hypoparathyroidism -Renal Failure |
|
Adverse effects of Vitamin D
|
-Hypercalcemia
|
|
Contraindications of Vitamin D use
|
Impaired renal function
(inc risk of hypercalcemia) |
|
Calcium salts indications
|
-hypocalcemia
-osteoporosis -osteomalacia -hypoparathyroidism -renal failure -intestinal osteodystrophy |
|
Adverse Effects Calcium Salts
|
Hypercalcemia
|
|
Drug interactions Calcium Salts
|
Thiazide Diuretics (dec calcium excretion)->HYPERCALCEMIA
When given IV, it can precipitate salts -Digoxin sensitizes heart to Calcium, so Calcium Salts cause wierd, severe heart problems |
|
Diphosphonate Etidronate
(Didronel) MOA |
-Analouge to Pyrophosphate
-Deacreases osteoclast activity and number->slows bone turnover |
|
Diphosphonate Etidronate
(Didronel) Indications |
Use for osteoporosis (treatment and prophylaxis)
Hypercalcemia of Malignancy |
|
Diphosphonate Etidronate
(Didronel) Administration |
Oral or IV
|
|
Diphosphonate Etidronate
(Didronel) Adverse Effects |
Decreased bone mineralization can lead to OSTEOMALACIA and BONE PAIN
|
|
PTH effectiveness with or without Diphosphonates
|
PTH alone is more effective than pth and diphosphonates together
|
|
Selective Estrogen Receptor Modulators (SERMS) For?
|
Women lacking estrogen who have increased bone resoprtion
-postmenopausal -post hysterectomy |
|
SERMS
eg Raloxifene |
Estrogen agonist activity (full or partial) at bone and Cardiovascular tissues
antagonist activity ot other organs (uterine and breast) |
|
Loop Diuretics and Calcium
|
Decreased calcium reabsorption (->increasd excretion)
Used for hypercalcemia |
|
Thiazide diuretics and calcium
|
Increasd Calcium reabsorption
->decreased excretion Used in hypercalCEURIA (ie stones) |
|
Causes of hypercalcemia
|
-Hyperparathyroidism
-hypervitaminosis D -Malignancies sometimes -Immobilizations |
|
Treatment for hypercalcemia
|
-Diphosphonates (chronic)
-Calcitonin (chronic) -Loop Diuretics (acute) |
|
Treatment of HyperCALCIURIA
|
Thiazide Diuretics
|
|
Causes of HYPOcalcemia
|
-Rickets(juv) and Osteomalacia(adult)
-Hypoparathyroidism -Renal Failure |
|
Rickets and osteomalacia due to?
|
Vitamin D deficiency
Lack of activation or resistance to Vitamin D calcium malabsorption |
|
Treatment for hypocalcemia
|
Vitamin D (or active analogs) and calcium supplements
|
|
Osteoporosis
|
Excessive resorption of calcium (and loss of bone)
Caused by aging, decreased estrogen (androgen?) and excess GC levels |
|
osteoporosis treatment
|
Vitamin D, Dietary Calcium, diphosphonate, calcitonin, PTH, SERMs (women only)
|
|
Pagets disease causes
|
-excessive formation and resportion of bone
-abnormal mutinucleated osteoclasts -pagetic bone (thick and abn) -Also causes Deafness, spinal cord compression, High output heart failure, pain |
|
Pagets Disease Treatment
|
Calcitonin, Diphosphonates to decrease bone mineralization
|
|
Uses for Vitmin D
|
Rickets, osteomalacia, hypocalcemia, hypoparathyroidism, osteoporosis, renal failure/disease
|
|
uses for PTH
|
Osteoporosis
|
|
Uses for calcitonin
|
Pagets Disease
Ostoeporosis hypercalcemia of malignancy |
|
Uses for SERMs or Estrogen
|
Osteoporosis
|
|
Uses of Diphosphonates
|
Osteoporosis, pagets disease, hypercalcemia
|
|
Uses of Loop diuretics
|
hypercalcemia
|
|
Uses of thazide diuretics
|
Hypercalceuria
|